Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Seasonal variation in hemoglobin a1c in korean patients with type 2 diabetes mellitus.

Kim YJ, Park S, Yi W, Yu KS, Kim TH, Oh TJ, Choi J, Cho YM.

J Korean Med Sci. 2014 Apr;29(4):550-5. doi: 10.3346/jkms.2014.29.4.550. Epub 2014 Apr 1.

2.

Seasonal variations in glycemic control of type 2 diabetes in Korean women.

Ryu OH, Lee S, Yoo HJ, Choi MG.

J Endocrinol Invest. 2014 Jun;37(6):575-81. doi: 10.1007/s40618-014-0080-y. Epub 2014 May 1.

PMID:
24789539
3.

[Evaluation of seasonal changes in hemoglobin A1c in diabetic patients].

Furuta M, Tomisaka R, Yamana A, Morita S, Ueyama M, Imanishi K, Ooishi C, Hara Y, Ooishi H, Sanke T.

Rinsho Byori. 2012 Jul;60(7):599-604. Japanese.

PMID:
22973717
4.

Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases.

Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura A, Kakei M, Noda M.

Medicine (Baltimore). 2014 Nov;93(23):e148. doi: 10.1097/MD.0000000000000148.

6.
7.

Seasonal variation of HbA1c in intensive treatment of children with type 1 diabetes.

Nordfeldt S, Ludvigsson J.

J Pediatr Endocrinol Metab. 2000 May;13(5):529-35.

PMID:
10803871
8.

Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study.

Vichayanrat A, Matawaran BJ, Wibudi A, Ferdous HS, Aamir AH, Aggarwal SK, Bajpai S.

J Diabetes. 2013 Sep;5(3):309-18. doi: 10.1111/1753-0407.12038. Epub 2013 May 28.

PMID:
23462227
9.

Association between total bilirubin and hemoglobin A1c in Korean type 2 diabetic patients.

Choi SW, Lee YH, Kweon SS, Song HR, Ahn HR, Rhee JA, Choi JS, Shin MH.

J Korean Med Sci. 2012 Oct;27(10):1196-201. doi: 10.3346/jkms.2012.27.10.1196. Epub 2012 Oct 2.

10.

Seasonal variability of glycated hemoglobin in a diabetic population from southern Europe.

Gomez-Huelgas R, Santamaria-Fernandez S, Guijarro-Merino R, Navajas-Luque F, Tinahones FJ, Roman-Teran CM, Picon MJ, Bernal-Lopez MR.

J Diabetes Complications. 2013 Nov-Dec;27(6):618-20. doi: 10.1016/j.jdiacomp.2013.04.013. Epub 2013 Jul 31.

PMID:
23916500
11.

Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

J Nephrol. 2001 Nov-Dec;14(6):461-71.

PMID:
11783602
12.

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

Diabetes Care. 1998 Apr;21(4):574-9.

PMID:
9571345
13.

Metabolic control in children with insulin dependent diabetes mellitus assessed by hemoglobin A1c.

Mortensen HB, Vestermark S, Kastrup KW.

Acta Paediatr Scand. 1982 Mar;71(2):217-22.

PMID:
6753471
14.

The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus.

Ko SH, Song KH, Ahn YB, Yoo SJ, Son HS, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK.

Metabolism. 2003 Jun;52(6):731-4.

PMID:
12800099
15.

Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables.

Ji LN, Lu JM, Guo XH, Yang WY, Weng JP, Jia WP, Zou DJ, Zhou ZG, Yu DM, Liu J, Shan ZY, Yang YZ, Hu RM, Zhu DL, Yang LY, Chen L, Zhao ZG, Li QF, Tian HM, Ji QH, Liu J, Ge JP, Shi LX, Xu YC.

BMC Public Health. 2013 Jun 21;13:602. doi: 10.1186/1471-2458-13-602.

16.

Medication adherence and associated hemoglobin A1c in type 2 diabetes.

Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, Holst EM, Nichol MB, Shi SG, Livengood KB, Walden S, Lubowski TJ.

Ann Pharmacother. 2004 Sep;38(9):1357-62. Epub 2004 Jul 6.

PMID:
15238621
18.
19.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
20.

Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study.

Ji L, Ma J, Li H, Mansfield TA, T'joen CL, Iqbal N, Ptaszynska A, List JF.

Clin Ther. 2014 Jan 1;36(1):84-100.e9. doi: 10.1016/j.clinthera.2013.11.002. Epub 2013 Dec 28.

Supplemental Content

Support Center